Navigation Links
Products containing specific probes for detecting alternative splice forms protected

ExonHit Therapeutics, today announced the grant of a major patent, US # 6,881,571, by the United States Patent and Trademark Office on microarray products allowing the specific detection of mRNAs produced by alternative splicing, covering microarrays optimised for the discovery of alternative RNA splicing events. The patent protects the probe configuration of a unique set of five oligonucleotides for the detection of each splice variant. There are many applications for this patent, including drug discovery, diagnostics, and compound screenings for efficacy or toxicity as well as screening patients for potential efficacy of therapeutics.

Alternative RNA Splicing is a critical step in the expression of most genes, which can result in the expression of several mRNAs encoding proteins with different functions from a single gene. Splicing events are implicated in numerous pathologies and can be altered by various stress events such as virus, toxic agents, and drug exposure.

The genome-wide patented probe configuration described in the patent is the basis for the microarrays in ExonHit's SpliceArray product line launched earlier this year. The genome profiling market is rapidly growing, and SpliceArrays are the only commercially available microarrays designed to detect alternative splicing. Current SpliceArray products include GPCR, Ion Channel, and Nuclear Receptor family SpliceArrays, as well as custom design services. An Apoptosis and Cytokine gene family array will be launched in the coming months. SpliceArrays are manufactured for ExonHit by Agilent Technologies.

The granting of this patent solidifies ExonHit's leadership in the field of expression profiling and positions the company as the only partner for the conception or use of gene profiling microarrays that include alternative RNA splicing. "The granting of these claims build on the company's core assets further expanding our IP position in the field of gene expression and profiling," sta
'"/>

Source:ExonHit


Page: 1 2

Related biology news :

1. Metal-containing compounds show promise as HIV weapon
2. Preventing a pandemic: Study suggests strategies for containing a flu outbreak
3. Rapid response was crucial to containing the 1918 flu pandemic
4. Scientists generate patient-specific stem cells, Science study says
5. Identification of specific genes predicts which patients will respond to Hepatitis C treatment
6. Eating, body weight regulated by specific neurons
7. Tool developed to silence genes in specific tissues using RNAi
8. Gene-specific Ebola therapies protect non-human primates from lethal disease
9. Unique dual target specificity of kinase inhibitor key for success against cancer
10. Serotonin, acting in a specific brain region, promotes sleep in fruit flies
11. A new male-specific gene in algae unveils an origin of male and female

Post Your Comments:
(Date:11/4/2009)..., BEDFORD, Mass., Oct. 20 /PRNewswire-FirstCall/ ...r of broadband technology and biometrics software,...uarter ended September 30, 2009. ,, Michael T...er, said, "Earlier today, we announced an agreemen...s to Lantiq, a new fabless semiconductor company b...
(Date:11/4/2009)..., WALL, N.J., Oct. 26 B...YI), a leader in finger-based biometric identifica...tity solutions at the AABB TXPO conference being h...ber 25-27 2009. BIO-key will provide hands-on prod...ication technology in booth #424. Also, at 5 PM on...
(Date:11/4/2009)..., CARLSBAD, Calif., Nov. 4 GenVau... William Brody, M.D., Ph.D., has joined its Board ...ntial Chair of the Salk Institute, is an acclaimed... to joining the Salk Institute, Dr. Brody served a...s a member of the National Academy of Engineering ...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7BIO-key(R) International Exhibiting at AABB TXPO 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3DIA 3rd Annual Clinical Trial Disclosure Workshop Offers Strategies for Creating Effective Registries and Results Databanks 54978 1DIA 3rd Annual Clinical Trial Disclosure Workshop Offers Strategies for Creating Effective Registries and Results Databanks 54978 2Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 1Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 2Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 3Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 4Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 5Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 6Acupuncture may bring relief for a common condition in women 54970 1Acupuncture may bring relief for a common condition in women 54970 2
... UCLA researchers have uncovered new clues that ma...le tissue behind the eyes, often causing them to b...actor Marty Feldman. , Scientists at UCLA’s Jules ... discovered defects in the infection-fighting T-ce... 1 in the Journal of Immunology, their study may d...
... Scientists at MIT have created an ocean model so ...oscopic plants they "sowed" have grown in populati...counterparts. , This model of the ocean is the fir...forests living in our oceans-tiny, single-celled g...lf the oxygen we breathe on Earth. And it does so ...
... Researchers have found a way to activate Epstein-...atients whose infection can then be manipulated to...d offer a novel way of treating many cancers assoc...ifferent types of lymphoma and nasopharyngeal and ...l Cancer Research, a team of radiologists and onco...
Other Biology News:UCLA study uncovers clues for why Graves' disease attacks the eyes 2MIT's ocean model captures diversity of underwater forests 2MIT's ocean model captures diversity of underwater forests 3Researchers wake up viruses inside tumors to image and then destroy cancers 2Researchers wake up viruses inside tumors to image and then destroy cancers 3
(Date:11/5/2009)...all/ -- BioSpecifics Technologies Corp. (Nasdaq: ...st-in-class collagenase-based products, today anno...ended September 30, 2009. ,, "We were extremel... Arthritis Advisory Committee unanimously recommen...) for the treatment of Dupuytren,s disease, and we...
(Date:11/5/2009)...re-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), a...or-based technologies to discover novel flavor ing...pply industries, today provided a corporate update...ter ended September 30, 2009. Revenues were $4.2 ... $4.0 million for the third quarter of 2008, an in...
(Date:11/5/2009)...wire-Asia-FirstCall/ -- BMP Sunstone,Corporation (...today announced,that the Company plans to release ...vember 9, 2009, after the market closes. , ...pm ET on November 9, 2009,to discuss third quarter...ialing 1-888-713-4211 or 1-617-213-4864 for intern...
(Date:11/5/2009)... a new look to Pro Repro , ...nal Reprographics, Orange County’s fastest g... Brooke Sanders to the company. Brooke joins the c...on of Brooke to the company represents continued a...hics., , ,Brooke brings with her over five years o...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...e call and webcast to begin after markets close at...April 14 Masimo Corporation (Nasdaq: MASI ), th...h Motion and Low-Perfusion pulse oximetry, today a...ial results for the period ended April 4, 2009 aft... A conference call to review the results will begi...
...stomer and New Vice President of Healthcare Brings...es , , BEAVERTON, Ore., April 14 Prolifiq Softw... has joined the company as vice president of healt...introduction of compliant, mobile email messaging ...ngly complex regulatory environment surrounding th...
...A, Calif., April 14 Oxygen Biotherapeutics, Inc. ...reached a development and commercial supply agreem...ceutical Services business unit to manufacture cli...erfluorocarbon (PFC) therapeutic oxygen carrier. O...North Carolina, facility which specializes in emul...
Other Biology Technology:Masimo to Report First Quarter 2009 Financial Results on May 5, 2009 2Masimo to Report First Quarter 2009 Financial Results on May 5, 2009 3Prolifiq Further Expands Into Medical Markets With New Hire Maureen A. Shaffer 2Prolifiq Further Expands Into Medical Markets With New Hire Maureen A. Shaffer 3Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs 2
.... Optimized for the rapid and efficient cloning of...es traditional TA cloning approaches by offering c...any as 25-fold more positive clones.Amplicons gene...e fully compatible.High efficiency cloning, no req...
GeneAmp High Fidelity PCR from Applied Biosystems
Guanylate Cyclase Blocking Peptide from Cayman Chemical
Expansion and Cryopreservation of Cells from Meridian Life Science, Inc.
Biology Products: